Results 141 to 150 of about 57,324 (279)

Risk of Insomnia Disorder in Japanese Cancer Patients: A Matched Cohort Study Using Employer‐Based Health Insurance Claims Data

Cancer Medicine, Volume 15, Issue 6, June 2026.
ABSTRACT Background Insomnia is a common clinical symptom that significantly impairs quality of life (QOL) and it frequently occurs in cancer patients. However, the risk of insomnia in Japanese cancer patients compared with cancer‐free patients has not yet been studied.
Risa Murakami, Hiroyuki Sato, Akihiro Hirakawa   +2 more
wiley   +1 more source

Comprehensive Genomic Profiles of Patients With Biliary Tract Cancer

Cancer Medicine, Volume 15, Issue 6, June 2026.
ABSTRACT Purpose Biliary tract cancer (BTC) represents a heterogeneous disease with highly lethal malignancy and poor clinical outcomes. Here, we aimed to evaluate its genomic profiles to promote the development of precision medicine for BTC. Materials and Methods Genomic analysis of 134 BTC patients was performed by using targeted panel sequencing in ...
Xia Yang, Tao Zhu, Xiaotong Hu, Zhinong Jiang, Hongchuan Jin   +4 more
wiley   +1 more source

Cancer Prevalence Among Large Cohort of Individuals With Down Syndrome: Implications for Screening Guidelines

Cancer Medicine, Volume 15, Issue 6, June 2026.
Individuals with Down syndrome have distinctive cancer profiles as compared with the general US population. Healthcare guidelines related to cancer screenings should reflect these unique profiles. ABSTRACT Introduction It is known that individuals with Down syndrome (DS) have a significantly different spectrum of malignancies and neoplasms.
Veronica Fitzpatrick, Akaninyene Noah, Anne Rivelli, Rachel Johnson, Melissa Zak, Joaquin Espinosa, Brian Chicoine   +6 more
wiley   +1 more source

Genomic profiling of gallbladder adenosquamous carcinoma

reservedGallbladder carcinoma (GBC) is a rare and aggressive malignancy with a 5-year overall survival of less than 20%. Aggressive biological behavior and delayed diagnosis are the major causes of the poor outcome of the disease.
MAFFII, EDOARDO
core  

Prevalence of Cancer Survivors in 2019 Among Patients Diagnosed Between 1975 and 2019: A Population‐Based Study in Japan

Cancer Medicine, Volume 15, Issue 6, June 2026.
Estimating Cancer Prevalence in Japan: Insights from the Osaka Cancer Registry ABSTRACT Owing to improved prognosis, cancer survivors are a growing population; however, little is known about their prevalence in Asian countries. This study estimated the prevalence and characteristics of cancer survivors in Japan, including long‐term survivors.
Haruka Kudo, Kayo Nakata, Kenji Kishimoto, Toshiki Ikawa, Yoko Iwaki, Yoshihiro Kuwabara, Toshitaka Morishima, Isao Miyashiro   +7 more
wiley   +1 more source

Rare pathological types of gallbladder cancer: Cases report. [PDF]

Medicine (Baltimore)
Wang H, Wang Z, Zhao Y, Xiang Y, Li J, Tuo H.   +5 more
europepmc   +1 more source

Acute Upper Gastrointestinal Bleeding is Associated With Poor Prognosis in Patients With Biliary Tract Cancer

Cancer Medicine, Volume 15, Issue 6, June 2026.
ABSTRACT Aim Upper gastrointestinal bleeding (UGIB) is associated with an unfavorable outcome in cancer patients. In patients with biliary tract cancer (BTC), data on the incidence, management, and prognostic implications of UGIB are limited. This study investigated the prevalence, treatment efficacy, and prognostic factors associated with UGIB in BTC.
Jan Christoph Schumacher, Sonja Lang, Philipp Kasper, Anna Martin, Dirk Waldschmidt, Martin Bürger, Ulrich Töx, Christoph Neumann‐Haefelin, Gabriel Allo   +8 more
wiley   +1 more source

Development and validation of a nomogram for predicting postoperative survival in gallbladder cancer. [PDF]

Transl Gastroenterol Hepatol
Qiu YY, Huang Q, Sun MQ, He XD, Han XL, Zhang N.   +5 more
europepmc   +1 more source

Cancer of the gallbladder – own experience

, 2014
Gallbladder cancer is a relatively rare cancer of the gastrointestinal tract, most commonly detected (approximately 95% of cases) in the most advanced clinical stage IV and burdened with high mortality rate. This is mainly due to the nonspecific symptoms
Cepowicz, D., Kamocki, Zb., Sawicka, E., Masiulaniec, P., Dawidziuk, T., Kędra, B., Gryko, M.   +6 more
core  

Meropenem‐Induced Possible Mixed Drug‐Induced Liver Injury With Cholestatic Evolution: A Case Report Evaluated Using the Updated RUCAM (2016)

Clinical Case Reports, Volume 14, Issue 6, June 2026.
ABSTRACT Drug‐induced liver injury (DILI) remains a diagnosis of exclusion and requires systematic causality assessment. Meropenem is generally considered hepatically safe; however, rare cases of idiosyncratic DILI have been reported. We describe a 33‐year‐old female who developed progressive elevation of liver tests following exposure to meropenem ...
Nidal Mutawodeh, Sarah Saife, Akram Shalaby, Kamaleldein Einar, Motasem Kamal, Malik Hijaz, Tariq Hamadneh   +6 more
wiley   +1 more source